XML 48 R41.htm IDEA: XBRL DOCUMENT v3.25.3
Summary of Significant Accounting Policies - Noncontrolling Interest (Details)
Sep. 30, 2025
Dec. 31, 2024
Napo Therapeutics    
Percentage of ownership interest by parent 89.00%  
Private Investors    
Percentage of ownership interest by non-controlling owners   11.00%